NORTH WALES, Pa.--(BUSINESS WIRE)--Teva Pharmaceuticals USA issues the following statement: “Teva was astonished by the Federal Trade Commission’s assertion yesterday that consumers would benefit from proposed legislation that would make it harder for generic and branded pharmaceutical companies to settle complex patent cases.
